tradingkey.logo

IDEXX Laboratories falls after BofA cuts PT on vet visit trends

ReutersApr 21, 2025 5:58 PM

Animal diagnostics maker IDEXX Laboratories' IDXX.O shares down 1.2% at $406.41

BofA Global Research cuts PT to $475 from $535 on vet visit declines

The new PT represents a 30% upside to the stock's last close

"IDXX's direct leverage to clinic visit volumes creates a tough setup given the weak readings through Q1 and April so far" - BofA

Brokerage says vet visit trends "leave a little room for upside revisions"

IDXX expects about a 2% decline in clinical visits for 2025 - co said on a Q4 conference call

Eight of 14 brokerages rate the stock "buy" or higher, six "hold"; their median PT is $502.13 - LSEG

Including session's move, IDXX down 1.5% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI